Home > Insider Trading > Filing (0001209191-21-007037)

Filing Details

Accession Number:: 0001209191-21-007037
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-02 21:47:34
Reporting Period:: 2021-02-01

Accepted Time:: 2021-02-02 21:47:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595893	Turning Point Therapeutics Inc.	TPTX	Pharmaceutical Preparations (2834)	463826166

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1785987	Yi Larson	C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-01	15,702	$54.03	18,406	No	4	M	Direct
Common Stock	Disposition	2021-02-01	4,783	$122.94	13,623	No	4	S	Direct
Common Stock	Disposition	2021-02-01	8,576	$123.70	5,047	No	4	S	Direct
Common Stock	Disposition	2021-02-01	2,143	$124.60	2,904	No	4	S	Direct
Common Stock	Disposition	2021-02-01	200	$126.07	2,704	No	4	S	Direct
Common Stock	Acquisiton	2021-02-02	14,298	$54.03	17,002	No	4	M	Direct
Common Stock	Disposition	2021-02-02	1,000	$127.58	16,002	No	4	S	Direct
Common Stock	Disposition	2021-02-02	400	$128.41	15,602	No	4	S	Direct
Common Stock	Disposition	2021-02-02	4,574	$129.80	11,028	No	4	S	Direct
Common Stock	Disposition	2021-02-02	7,267	$130.58	3,761	No	4	S	Direct
Common Stock	Disposition	2021-02-02	1,057	$131.73	2,704	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	15,702	$0.00	15,702	$54.03
Common Stock	Stock Option (right to buy)	Disposition	2021-02-02	14,298	$0.00	14,298	$54.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
296,695		2029-08-25	No	4	M	Direct
282,397		2029-08-25	No	4	M	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 20, 2020.
The Reporting Person acquired 86 shares on June 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 396 shares on December 10, 2020 pursuant the ESPP.
The weighted average sale price for the transaction reported was $122.94, and the range of prices were between $122.28 and $123.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $123.70, and the range of prices were between $123.29 and $124.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $124.60, and the range of prices were between $124.34 and $125.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $126.07, and the range of prices were between $125.58 and $126.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $127.58, and the range of prices were between $127.00 and $127.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $128.41, and the range of prices were between $128.12 and $128.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $129.80, and the range of prices were between $129.215 and $130.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $130.58, and the range of prices were between $130.25 and $131.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $131.73, and the range of prices were between $131.38 and $132.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
25% of the shares vested on August 26, 2020 with the remaining shares vesting in equal monthly installments over the following three years thereafter.